Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models.
Bergman AM, Adema AD, Balzarini J, Bruheim S, Fichtner I, Noordhuis P, Fodstad O, Myhren F, Sandvold ML, Hendriks HR, Peters GJ. Bergman AM, et al. Invest New Drugs. 2011 Jun;29(3):456-66. doi: 10.1007/s10637-009-9377-7. Epub 2010 Jan 12. Invest New Drugs. 2011. PMID: 20066470 Free PMC article.
Combination chemotherapy studies with gemcitabine.
van Moorsel CJ, Veerman G, Bergman AM, Guechev A, Vermorken JB, Postmus PE, Peters GJ. van Moorsel CJ, et al. Among authors: bergman am. Semin Oncol. 1997 Apr;24(2 Suppl 7):S7-17-S7-23. Semin Oncol. 1997. PMID: 9194475 Review.
Mechanisms of synergism between gemcitabine and cisplatin.
van Moorsel CJ, Veerman G, Vermorken JB, Voorn DA, Kroep JR, Bergman AM, Pinedo HM, Peters GJ. van Moorsel CJ, et al. Among authors: bergman am. Adv Exp Med Biol. 1998;431:581-5. doi: 10.1007/978-1-4615-5381-6_112. Adv Exp Med Biol. 1998. PMID: 9598132 Clinical Trial. No abstract available.
165 results